A positive correlation between HMGA1 increased expression levels and worse breast cancer clinicopathological features and prognosis has been established (11, 12); however, there are also contrasting data showing that in BRCA2-mutated patients, HMGA1 expression is a good prognostic factor for breast cancer outcome (13). This evidence concerns the gene BRCA2 and breast carcinoma.